Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-14-025144
Filing Date
2014-06-11
Accepted
2014-06-11 16:23:37
Documents
1
Period of Report
2014-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3795
  Complete submission text file 0001140361-14-025144.txt   5277
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9620 MEDICAL CENTER DRIVE C/O REXAHN PHARMACEUTICALS, INC. ROCKVILLE MD 20850
Business Address
Beever Charles (Reporting) CIK: 0001361687 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 14904892